NeoGenomics, Inc. (NEO) by event type
NEO moves most on analyst upgrades — a median of -3.78% at 30 minutes across 11 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the NEO overview →
How NEO reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,712 of 2,717 | 11 | -3.78% | 36% | -2.79% |
| Analyst downgrades 2,519 of 2,603 | 16 | -1.82% | 38% | -0.85% |
| Rating reiterations 2,680 of 3,522 | 72 | -0.12% | 46% | -0.43% |
| Price-target raises 1,774 of 1,790 | 12 | -1.01% | 25% | -1.19% |
| Price-target cuts 176 of 1,527 | 18 | +0.23% | 61% | +0.27% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how NEO usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · Price-target cuts → · NEO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Align Technology, Inc. (ALGN) | 407 | -0.00% | 50% |
| ALLIQUA BIOMEDICAL (ALQA) | 407 | -0.11% | 43% |
| Vericel Corporation (VCEL) | 406 | -0.19% | 40% |
| SPRING BANK PHARMACEUTICALS (SBPH) | 404 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.